Navigation Links
Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth–--Austerity-measures-will-impact-pharmaceutical-market-growth.html


The prescription pharma market in France was valued at $38.8bn in sales in 2009, having by 3.1% (CAGR; 2005–09). Key growth drivers include growing use of chronic high-value innovative treatments driven by an aging population, high public healthcare expenditure as proportion of total healthcare expenditure, physician preference for prescribing branded drugs as well as high patient brand loyalty.

Features and benefits

* Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in France

* Assesses the size of the French pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies

* Examines the French generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion

* Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis


Despite having a higher birth rate than most European countries, with its ageing population France is encountering difficulties in handling its health account deficit, a situation made worse by the economic downturn. Hence France has turned towards social system reforms and austerity measures. Despite having a favourable market for innovative and expensive drugs a range of cost-cutting measures such as pricing and reimbursement cuts will have a negative impact on the French pharmaceutical market. Once considered the immature generics market, France has considerably increased its generics uptake although there is still a significant scope for improvement. Physicians' resistance to generics use remains the greatest obstacle with adequate physicians' financial incentives necessary in the future.

Your key questions answered

* Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in France

* Quantify the size and growth of the prescription pharmaceutical market in France, analyzing key therapy areas, brands and companies

* Assess drivers and resistors of generic and biosimilars uptake in France

To order this report:

: France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Innovative Drug Discovery in Emerging Markets
2. Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
3. Reportlinker Adds Cosmetic Surgery Products
4. Reportlinker Adds Regenerative Medicine Markets
5. Reportlinker Adds Womens Health Diagnostic Testing
6. Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry
7. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
8. Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia
9. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
10. Reportlinker Adds Mammography World Markets
11. Reportlinker Adds Molecular Diagnostics in Cancer Testing
Post Your Comments:
(Date:12/1/2015)... , December 1, 2015 ... Injectables, Topical Contraceptives, Male Condoms, Female Condoms, ... Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent ... Share, Growth, Trends and Forecast 2014 - ... Market Research (TMR).The report states that the ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... For the millions of people who use ... launched the VaPro Plus Pocket™ touch free hydrophilic intermittent catheter. “Hollister Continence Care ... portfolio,” said Michael Gresavage, Vice President North America. "We designed our VaPro Plus ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
(Date:11/30/2015)... ... November 30, 2015 , ... Third ... today that it has officially launched a sleek, mobile-ready and user-centric redesigned website. ... company’s new website clearly outlines the benefits that its SEO services provide to ...
(Date:11/30/2015)... ... , ... The National Association of Professional Women (NAPW) honors ... Circle. She is recognized with this prestigious distinction for leadership in estate sales and ... than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome ...
Breaking Medicine News(10 mins):